1 Min Read
May 16 (Reuters) - EyeGate Pharmaceuticals Inc:
* EYEGATE PHARMACEUTICALS INC - ON MAY 15, BOARD INCREASED SIZE OF BOARD FROM SEVEN DIRECTORS TO EIGHT DIRECTORS - SEC FILING Source bit.ly/2KuxceA Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.